Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Liquidia Corp (LQDA)

Liquidia Corp (LQDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
MarketBeat.com
Liquidia Q1 Earnings Call Highlights MarketBeat - Mon May 11, 10:07AM CDT

Liquidia (NASDAQ:LQDA) reported sharply higher first-quarter 2026 sales and profitability as executives said the launch of YUTREPIA continued to gain traction in pulmonary arterial hypertension and pulmonary...

LQDA : 61.77 (+2.98%)
Liquidia Corporation Reports First Quarter 2026 Financial Results GlobeNewswire - Mon May 11, 5:30AM CDT

YUTREPIA ® (treprostinil) inhalation powder net product sales of approximately $130 million in the first quarter of 2026 More than 4,500 unique patient prescriptions and approximately 3,750 patients...

LQDA : 61.77 (+2.98%)
Liquidia: The Market Has Already Priced In What Tomorrow's Report Will Actually Say Barchart - Sun May 10, 4:00PM CDT

Barchart Research What to Expect from LQDA Earnings LQDA Generated May 8, 2026 Current Price $42.30 EPS Estimate $$0.34 Consensus Rating Strong Buy Average Move 4.26% Liquidia: The Market Has Already Priced...

LQDA : 61.77 (+2.98%)
Liquidia: The Market Has Already Priced In What Tomorrow's Report Will Actually Say Barchart - Sat May 9, 4:00PM CDT

Barchart Research What to Expect from LQDA Earnings LQDA Generated May 8, 2026 Current Price $42.30 EPS Estimate $$0.34 Consensus Rating Strong Buy Average Move 4.26% Liquidia: The Market Has Already Priced...

LQDA : 61.77 (+2.98%)
Liquidia: The Market Has Already Priced In What Tomorrow's Report Will Actually Say Barchart - Fri May 8, 4:07PM CDT

Barchart Research What to Expect from LQDA Earnings LQDA Generated May 8, 2026 Current Price $42.30 EPS Estimate $$0.34 Consensus Rating Strong Buy Average Move 4.26% Liquidia: The Market Has Already Priced...

LQDA : 61.77 (+2.98%)
Liquidia Corporation to Participate in Upcoming Investor Conferences GlobeNewswire - Wed May 6, 7:30AM CDT

MORRISVILLE, N.C., May 06, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging...

LQDA : 61.77 (+2.98%)
Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026 GlobeNewswire - Mon May 4, 7:30AM CDT

MORRISVILLE, N.C., May 04, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging...

LQDA : 61.77 (+2.98%)
Liquidia Corporation to Participate in Upcoming Investor Conferences GlobeNewswire - Tue Apr 7, 7:00AM CDT

MORRISVILLE, N.C., April 07, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging...

LQDA : 61.77 (+2.98%)
Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update GlobeNewswire - Thu Mar 5, 5:30AM CST

Achieved YUTREPIA ® net product sales of $148.3 million for the full year 2025 with $90.1 million in the fourth quarter More than 3,600 unique prescriptions received and 2,900 patients treated to date...

LQDA : 61.77 (+2.98%)
Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026 GlobeNewswire - Thu Feb 26, 6:00AM CST

MORRISVILLE, N.C., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular diseases,...

LQDA : 61.77 (+2.98%)

Barchart Exclusives

Berkshire Hathaway Gave Up on This Underperforming Dividend Stock, But It May Be Time for You to Buy the Dip Barchart - Wed May 20, 6:30PM CDT
Berkshire Hathaway dumped its stake in Domino's Pizza in Q1. The stock has a healthy dividend yield of 2.6% and is trading at reasonable valuations though. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.